Literature DB >> 10937845

Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

F Y Demirci1, R Küçükkaya, K Akarçay, N Kir, T Atamer, H Demirci, E Ongör.   

Abstract

UNLABELLED: The purpose of this study is to evaluate the ocular findings in patients with the primary antiphospholipid syndrome (APS). PATIENTS AND METHODS: Twenty-two patients (44 eyes) with primary APS (17 women, 5 men) were examined. All patients were younger than 50 years (median age; 37.5 years). In 18 patients, fundus flourescein angiography was performed in addition to the ophthalmologic examination.
RESULTS: Sixteen patients (72.7%) described visual symptoms. Anterior segment was normal in 19 patients (86.4%). Posterior segment abnormalities were observed in 15 patients (68.2%). Venous dilatation and tortuosity were the most common ocular findings. Retinal vascular occlusive disease was detected in 5 patients (22.7%). Flourescein angiography abnormalities were noted in 14 of the 18 patients (77.8%). The most common angiographic finding was pigment epithelial window defects.
CONCLUSIONS: Our results indicate that posterior eye segment involvement is relatively common in the primary APS. It also seems that the screening for APS is important in young patients with retinal vascular occlusion, especially in those without conventional risk factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10937845     DOI: 10.1023/a:1006305705080

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  33 in total

Review 1.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

2.  Chorioretinopathy in primary antiphospholipid syndrome: a case report.

Authors:  E P Boets; C G Chaar; K Ronday; J E Keunen; F C Breedveld
Journal:  Retina       Date:  1998       Impact factor: 4.256

3.  Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome.

Authors:  D Dori; Y A Gelfand; B Brenner; B Miller
Journal:  Retina       Date:  1997       Impact factor: 4.256

4.  Vaso-occlusive retinopathy in the primary anti-phospholipid antibody syndrome.

Authors:  J F Acheson; R M Gregson; P Merry; W E Schulenburg
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

5.  Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy.

Authors:  B Wiechens; J O Schröder; B Pötzsch; R Rochels
Journal:  Am J Ophthalmol       Date:  1997-06       Impact factor: 5.258

6.  Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

Authors:  H P McNeil; C N Chesterman; S A Krilis
Journal:  Br J Haematol       Date:  1989-12       Impact factor: 6.998

Review 7.  Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.

Authors:  J H Rand
Journal:  Am J Med Sci       Date:  1998-08       Impact factor: 2.378

Review 8.  The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.

Authors:  A K Vine; M M Samama
Journal:  Surv Ophthalmol       Date:  1993 Jan-Feb       Impact factor: 6.048

9.  Visual symptoms associated with the presence of a lupus anticoagulant.

Authors:  S R Levine; J W Crofts; G R Lesser; J Floberg; K M Welch
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

Review 10.  Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).

Authors:  J Ordi-Ros; P Pérez-Pemán; J Monasterio
Journal:  Haemostasis       Date:  1994 May-Jun
View more
  8 in total

Review 1.  Ocular and systemic causes of retinopathy in patients without diabetes mellitus.

Authors:  Jayant Venkatramani; Paul Mitchell
Journal:  BMJ       Date:  2004-03-13

Review 2.  Looking into the eyes of patients with antiphospholipid syndrome.

Authors:  D Yehudai; Y Shoenfeld; E Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 3.  Neurologic manifestations of the antiphospholipid syndrome.

Authors:  D Tanne; S Hassin-Baer
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

4.  Primary antiphospholipid syndrome unusual presentation in a seventy two year old man.

Authors:  A Ajaj; E Luhishi; E Metaraiah
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

5.  Atypical presentation of antiphospholipid syndrome: a case report.

Authors:  Cesare Mariotti; Alfonso Giovannini; Michele Reibaldi; Andrea Saitta; Francesca Viti; Michele Nicolai
Journal:  Case Rep Ophthalmol       Date:  2014-11-26

6.  Retinopathy in lupus transitioned to Kikuchi-Fujimoto disease.

Authors:  Kelly S Rue; Damien C Rodger; Narsing A Rao
Journal:  Am J Ophthalmol Case Rep       Date:  2016-06-15

7.  Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Authors:  Stephan G Dixon; Carl T Bruce; Charles J Glueck; Robert A Sisk; Robert K Hutchins; Vybhav Jetty; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-08-09

8.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.